علاج اعتلال الكلى السكري مع داء الكلى المزمن وتاريخ من السكتة الدماغية الإقفارية غير القلبية المنشأ أو النوبة الإقفارية العابرة

References

DOI: 10.1016/j.nefro.2024.11.002

In patients with T1D or T2D and CKD and a previous non-cardioembolic ischemic stroke or transient ischemic stroke, the long-term use of antiplatelet therapy to reduce the risk of recurrent stroke is recommended.

Dual antiplatelet therapy (with low-dose aspirin and a P2Y12 inhibitor) after acute non-cardioembolic ischemic stroke/transient ischemic attack in patients with T1D or T2D and CKD followed by single antiplatelet therapy should be considered.